Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 979

• Price / Volume Information    Yesterday's Closing Price: $54.92 Daily Weekly Monthly 20 Day Moving Average: 1,554,412 shares Shares Outstanding: 61.31 (millions) Market Capitalization: $3,367.24 (millions) Beta: 2.24 52 Week High: $57.88 52 Week Low: $23.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 25.82% 25.72% 12 Week 73.25% 71.52% Year To Date 73.14% 72.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD. - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - abitting@twistbioscience.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer and Chair of the Board of Adam Laponis - Chief Financial Officer Robert F. Werner - Chief Accounting Officer Nelson C. Chan - Director Robert Chess - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/04/26 Share - Related Items Shares Outstanding: 61.31 Most Recent Split Date: (:1) Beta: 2.24 Market Capitalization: $3,367.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.54 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.83 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.38 Price/Cash Flow: - Price / Sales: 8.60 EPS Growth vs. Year Ago Period: 5.66% vs. Previous Quarter: -11.11% Sales Growth vs. Year Ago Period: 16.89% vs. Previous Quarter: 4.74% ROE 12/31/25 - -27.16 09/30/25 - -27.40 06/30/25 - -29.03 ROA 12/31/25 - -19.92 09/30/25 - -20.33 06/30/25 - -21.77 Current Ratio 12/31/25 - 3.78 09/30/25 - 3.64 06/30/25 - 3.90 Quick Ratio 12/31/25 - 3.37 09/30/25 - 3.33 06/30/25 - 3.60 Operating Margin 12/31/25 - -32.03 09/30/25 - -33.60 06/30/25 - -37.00 Net Margin 12/31/25 - -19.56 09/30/25 - -20.63 06/30/25 - -23.51 Pre-Tax Margin 12/31/25 - -19.33 09/30/25 - -20.43 06/30/25 - -23.41 Book Value 12/31/25 - 7.44 09/30/25 - 7.84 06/30/25 - 7.92 Inventory Turnover 12/31/25 - 7.01 09/30/25 - 7.53 06/30/25 - 7.79 Debt-to-Equity 12/31/25 - 0.03 09/30/25 - 0.03 06/30/25 - 0.03 Debt-to-Capital 12/31/25 - 3.18 09/30/25 - 3.07 06/30/25 - 3.04

Powered by Zacks Investment Research ©